Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin- dependent diabetic patients: Influence of apolipoprotein E polymorphism

Metabolism: Clinical and Experimental

Volumn 45, Issue 1, 1996, Pages 63-71

  Reznik, Yves ^a   Pousse, Pascale ^a   Herrou, Michel ^a   Morello, Rémy ^a   Mahoudeau, Jacques ^a   Drosdowsky, Michel A ^a   Fradin, Sabine ^a  

^a CHU CÔTE DE NACRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LIPOPROTEIN; RETINOL PALMITATE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; LIPID ANALYSIS; LIPOPROTEIN METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029920987     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90201-2     Document Type: Article

References (50)

1. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: An epidemiological view. Diabetes Metab Rev 3:463-524, 1987
2. West KM, Ahuja MS, Bennett PH, et al: The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 6:361-369, 1983
3. Fontbonne A, Eschwege E, Cambien JL, et al: Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 32:300-304, 1989
4. Laakso M, Voutilainen E, Pyörälä K, et al: Association of low HDL and HDL2 cholesterol with coronary heart disease in non-insulin-dependent diabetics. Arteriosclerosis 5:653-658, 1985
5. Laakso M, Lehto S, Penttilä I, et al: Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88:1421-1430, 1993
6. Stewart MW, Laker MF, Dyer RG, et al: Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. Arterioscler Thromb 13:1046-1052, 1993
7. Austin MA, Breslow JL, Hennekens CH, et al: LDL subclass patterns and risk of myocardial infarction. JAMA 260:1917-1921, 1988
8. Hamsten A: Hypertriglyceridemia, triglyceride-rich lipoproteins and coronary heart disease. Baillière's Clin Endocrinol Metab 4:895-922, 1990
9. Zilversmit DB: Atherogenesis: A postprandial phenomenon. Circulation 60:473-485, 1979
10. Simons LA, Dwyer T, Simons J, et al: Chylomicrons and chylomicron remnants in coronary artery disease: A case-control study. Atherosclerosis 65:181-189, 1987
11. Simpson HS, Williamson CM, Olivecrona T, et al: Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 85:193-202, 1990
12. Groot PHE, van Stiphout WAHJ, Krauss XH, et al: Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11:653-662, 1991
13. Patsch JR, Miesenböck G, Hopferwieser T, et al: Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12:1336-1345, 1992
14. Cohn JS, McNamara JR, Cohn S, et al: Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 29:469-478, 1988
15. Lewis GF, O'Meara NM, Soltys PA, et al: Postprandial lipoprotein metabolism in normal and obese subjects: Comparison after the vitamin A fat-loading test. J Clin Endocrinol Metab 71:1041-1050, 1990
16. O'Meara NM, Lewis GF, Cabana VG, et al: Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses. J Clin Endocrinol Metab 75:465-471, 1992
17. Weintraub MS, Eisenberg S, Breslow JL: Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 80:1571-1577, 1987
18. Brenninkmeijer BJ, Stuyt PMJ, Demacker PNM, et al: Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype. J Lipid Res 28:361-370, 1987
19. Brown AJ, Roberts DCK: The effects of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arterioscler Thromb 11:1737-1744, 1991
20. Boerwinkle E, Brown S, Sharrett AR, et al: Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet 54:341-360, 1994
21. McLean JW, Elshourbagy NA, Chang DJ, et al: Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant. J Biol Chem 259:6498-6504, 1984
22. Gregg RE, Zech LA, Schaefer EJ, et al: Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78:815-821, 1986
23. Weisgraber KH, Innerarity TL, Mahley RW: Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 257:2818-2821, 1982
24. Brewer HB, Zech LA, Gregg RE, et al: Type III hyperlipoproteinemia: Diagnosis, molecular defects, pathology, and treatment. Ann Intern Med 98:623-640, 1983
25. Shriver MD, Boerwinkle E, Hewett-Emmett D, et al: Frequency and effects of apolipoprotein E polymorphism in Mexican-American NIDDM subjects. Diabetes 40:334-337, 1991
26. Laakso M, Kesäniemi A, Kervinen K, et al: Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes. Br Med J 303:1159-1162, 1991
27. Fuller JH, Shipley MJ, Rose G, et al: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall Study. Br Med J 287:867-870, 1983
28. Lewis GF, O'Meara NM, Soltys PA, et al: Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 72:934-944, 1991
29. Syvänne M, Hilden H, Taskinen MR: Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease. J Lipid Res 35:15-26, 1994
30. Weber P, Schrezenmeir J, Fenselau S, et al: Prolonged postprandial increment in triglycerides and decreased postprandial response of very low density lipoproteins in type 2 diabetics following an oral lipid load. Ann NY Acad Sci 683:315-321, 1993
31. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548, 1990
32. Tai MM: A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 17:152-154, 1994
33. Winer BJ, Brown DR, Michels KM: Statistical Principles in Experimental Design (ed 3 rev). New York, NY, McGraw-Hill, 1991
34. Bhushan V: Inférence statistique. Québec, Canada, Les Presses de l'Université Laval, 1985
35. Weintraub MS, Eisenberg S, Breslow JL: Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. J Clin Invest 79:1110-1119, 1987
36. Chen YDI, Swami S, Skowronski R, et al: Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 76:172-177, 1993
37. Schneeman BO, Kotite L, Todd KM, et al: Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci USA 90:2069-2073, 1993
38. Cohn JS, McNamara JR, Cohn S, et al: Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J Lipid Res 29:925-936, 1988
39. Cohn JS, Johnson EJ, Millar JS, et al: Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 34:2033-2040, 1993
40. Blum CB: Dynamics of apolipoprotein E metabolism in humans. J Lipid Res 23:1308-1316, 1982
41. Descamps O, Bilheimer D, Herz J: Insulin stimulates receptor-mediated uptake of apoE-enriched lipoproteins and activated alpha2-macroglobulin in adipocytes. J Biol Chem 268:974-981, 1993
42. Windler E, Chao YS, Havel RJ: Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. J Biol Chem 255:8303-8307, 1980
43. Herz J: The LDL-receptor-related protein. Portrait of a multifunctional receptor. Curr Opin Lipidol 4:107-113, 1993
44. Yen FT, Mann CJ, Guermani LM, et al: Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein. Biochem 33:1172-1180, 1994
45. Syvänne M, Rosseneu M, Labeur C, et al: Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: A preliminary report. Atherosclerosis 105:25-34, 1994
46. Curtiss LK, Witztum JL: Plasma apolipoproteins AI, AII, B, CI and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 34:452-461, 1985
47. Ekman R, Nilsson-Ehle P: Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue. Clin Chim Acta 63:29-35, 1975
48. Kinoshita M, Arai H, Fukasawa M, et al: Apolipoprotein E enhances lipid exchange between lipoproteins mediated by cholesteryl ester transfer protein. J Lipid Res 34:261-268, 1993
49. Patsch JR, Prasad S, Gotto AM, et al: Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. J Clin Invest 74:2017-2023, 1984
50. Surguchov AP, Boerwinkle E, Sharett AR, et al: Apolipoprotein E genotype and lipid transport: Insight into the role of the E4 allele. Atherosclerosis 106:119-121, 1994